# ELTROMBOPAG OLAMINE
> **ANDA209938** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2026-07-13
## Drug
- **FDA Application Number:** ANDA209938
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELTROMBOPAG OLAMINE
- **Generic name:** Eltrombopag Olamine
- **Active ingredients:** ELTROMBOPAG OLAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2026-07-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209938)
---
*MORVS · CC0 1.0*